- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01418300
Comparison of Conventional Triple Therapy Versus Sequential Therapy for H. Pylori in Peptic Ulcer Disease: Prospective Randomized Trial
April 26, 2015 updated by: Jun-Won Chung
The purpose of this study is to improve first line Helicobacter pylori eradication rate and to compare the sequential versus conventional triple therapy.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
159
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Incheon, Korea, Republic of
- Gil Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- peptic ulcer diseae
- two test positive rapid urease test, culture, histology
Exclusion Criteria:
- lactating or pregnant
- previous stomach surgery
- severe underlying disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: sequential therapy
first five day amoxicillin+PPI later five day PPI+clarithromycin+metronidazole
|
sequential: lansoprazole 30mg bid+amoxicillin 100mg bid for first five day lansoprazole 30mg bid+clarithromycin 500mg bid+metronidazole 500mg for 5day conventional tripe lansoprazole 30mg bid+clarithromycin 500mg bid+amoxicillin 1000mg bid
|
Active Comparator: conventional triple thearpy
PPI+amoxicillin+clarithromycin
|
sequential: lansoprazole 30mg bid+amoxicillin 100mg bid for first five day lansoprazole 30mg bid+clarithromycin 500mg bid+metronidazole 500mg for 5day conventional tripe lansoprazole 30mg bid+clarithromycin 500mg bid+amoxicillin 1000mg bid
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
the eradication rate by urea breath test
Time Frame: 4-6 week later after completion of therapy
|
to compare the eradication rate (intention-to-treat and per protocol) by urea breath test at least four weeks after treatment
|
4-6 week later after completion of therapy
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2010
Primary Completion (Actual)
August 1, 2011
Study Completion (Actual)
December 1, 2011
Study Registration Dates
First Submitted
August 13, 2011
First Submitted That Met QC Criteria
August 16, 2011
First Posted (Estimate)
August 17, 2011
Study Record Updates
Last Update Posted (Estimate)
April 28, 2015
Last Update Submitted That Met QC Criteria
April 26, 2015
Last Verified
August 1, 2011
More Information
Terms related to this study
Other Study ID Numbers
- GMC2010-088
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Helicobacter Infected Patients
-
Rabin Medical CenterUnknownHyperthyroidism | Thyroid Cancer Patients | Helicobacter Pylori Infected Patients
-
ImevaXCompletedHelicobacter Pylori Infected Subjects | Helicobacter Pylori Naive SubjectsGermany
-
Azienda Ospedaliera di PerugiaCompleted
-
Hospices Civils de LyonCompleted
-
Università Vita-Salute San RaffaeleIRCCS San Raffaele; Merck Sharp & Dohme LLCUnknownHIV-1 Infected Patients | Fold-change Resistance | Resistance MutationsItaly
-
ANRS, Emerging Infectious DiseasesBicetre Hospital; Pitié-Salpêtrière HospitalUnknownHIV Infected Patients With Cancer Treated by ICPiFrance
-
Assistance Publique Hopitaux De MarseilleCompleted
-
Fundación FLS de Lucha Contra el Sida, las Enfermedades...CompletedAging-related Inflammation in HIV-infected PatientsSpain
-
Sohag UniversityRecruitingHelicobacter Pylori Infection in Patients With Chronic TonsillitsEgypt
-
National Taiwan University HospitalUnknownPatient With Invasive Cervical Carcinoma | Patient With CIN Lesion | Patient With HPV Infected Patients Without Histopathologic Lesion | Normal Populations.Taiwan
Clinical Trials on sequential versus triple
-
University of AlbertaCanadian Institutes of Health Research (CIHR); Alberta Innovates Health Solutions and other collaboratorsCompleted
-
National Taiwan University HospitalCompleted
-
Shandong UniversityCompletedHelicobacter Pylori Eradication RateChina
-
Fu Jen Catholic University HospitalActive, not recruitingHelicobacter PyloriTaiwan
-
University Hospital, GhentViiV HealthcareRecruiting
-
Dow University of Health SciencesCompleted
-
Ying HUANGTang-Du Hospital; Beijing Children's Hospital; Guangzhou Women and Children's... and other collaboratorsRecruitingHelicobacter InfectionsChina
-
RezoluteCompletedCongenital HyperinsulinismUnited States, Denmark, United Kingdom, Russian Federation, Spain, Bulgaria, Canada, Georgia, Germany, Israel, Turkey
-
University of ManchesterRoyal Children's HospitalCompleted
-
Peking UniversityChina International Medical FoundationCompletedHead and Neck Cancer | Radiotherapy | Triple Pre-rehabilitationChina